C07D 513/06
Peri-condensed systems
C07D513/06 (Peri-condensed systems) appears on 136 US grants and 107 published applications in this corpus.
Search patents in C07D- Granted patents
- 136
- Published applications
- 107
- Assignees
- 93
- Inventors
- 521
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 5 | 0 |
| 1991 | 6 | 0 |
| 1992 | 5 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 5 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 1 |
| 2002 | 4 | 1 |
| 2003 | 1 | 5 |
| 2004 | 3 | 2 |
| 2005 | 3 | 1 |
| 2006 | 3 | 5 |
| 2007 | 2 | 3 |
| 2008 | 1 | 2 |
| 2009 | 2 | 3 |
| 2010 | 2 | 5 |
| 2011 | 0 | 1 |
| 2012 | 3 | 5 |
| 2013 | 2 | 5 |
| 2014 | 1 | 5 |
| 2015 | 6 | 4 |
| 2016 | 4 | 12 |
| 2017 | 4 | 5 |
| 2018 | 8 | 5 |
| 2019 | 5 | 5 |
| 2020 | 6 | 6 |
| 2021 | 7 | 1 |
| 2022 | 2 | 5 |
| 2023 | 2 | 12 |
| 2024 | 2 | 5 |
| 2025 | 4 | 3 |
| 2026 | 3 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Materials for organic electroluminescent devices15 Sep 2026US 12,735,436 B2Universal Display Corporation
- Conjugation-fused bipolar redox-active molecule, preparation method, and application thereof5 May 2026US 12,617,804 B2Hangzhou Normal University
- Nucleic acid modifying reagents and uses thereof10 Mar 2026US 12,571,031 B2Promega Corporation
- Synthesis of sulfonamide intermediates14 Oct 2025US 12,441,681 B2Amgen Inc.
- Light emitting device and polycyclic compound for the same5 Aug 2025US 12,378,259 B2Samsung Display Co., Ltd.
- Tricyclic pyridones and pyrimidones9 Oct 2025US 2025/0313577 A1Erasca, Inc.
- Stimulator of interferon genes (sting) modulators, and compositions and methods thereof29 May 2025US 2025/0171461 A1
- Rare earth complex6 Mar 2025US 2025/0074925 A1Sagami Chemical Research Institute
- Preparation methods of quinolone compounds and intermediates thereof5 Dec 2024US 2024/0400522 A1Chongqing University of Arts and Sciences
- Amide and urea-containing tricyclic kras inhibitors21 Nov 2024US 2024/0383921 A1Erasca, Inc.
Most cited
By later US patents
- Substituted heterocycle fused gamma-carbolines105US 7,071,186 B2Bristol-Myers Squibb Pharma Company · 2006
- Substituted heterocycle fused γ-carbolines103US 7,183,282 B2Bristol-Myers Squibb Pharma Company · 2007
- Azadecalin Glucocorticoid receptor modulators43US 7,678,813 B2Corcept Therapeutics, Inc. · 2010
- Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-HIV agent33US 5,519,016 AUbe Industries, Ltd. · 1996
- 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds30US 4,636,516 AYamanouchi Pharmaceutical Co., Ltd. · 1987